FDA Issues Grants for Clinical Trial Research for Orphan Diseases
By EsqSocial Corporation 23/10/20
In an effort to enhance development of medical products for orphan diseases (or rare diseases), the U.S. Food and Drug Administration announced on October 8, 2020 that it awarded six new grants for clinical trial research, including a grant for ustekinumab (STELARA®) for the prevention of graft versus host disease. STELARA®, marketed by Janssen Biotech, is currently approved for the treatment of Crohn’s disease, ulcerative colitis, psoriasis, and psoriatic arthritis....
By: Goodwin